ロード中...

Sequential Bioequivalence Trial Designs with Increased Power and Controlled Type I Error Rates

Methods to implement two-stage designs in two-treatment, two-sequence, and two-period crossover bioequivalence studies have only recently been developed. The two-stage methods have so far only been described for a targeted study power of 80%. Since it is sometimes desirable to increase the targeted...

詳細記述

保存先:
書誌詳細
第一著者: Fuglsang, Anders
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691437/
https://ncbi.nlm.nih.gov/pubmed/23543603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-013-9475-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!